Nasdaq
$40.39▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.82BShares out 45.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 5d agoAfter-hours26.10.20 08:004Ownership#●●●
Septerna, Inc.
Insider Elizabeth Bhatt of Septerna, Inc. reported a change in beneficial ownership of securities as of October 15, 2026. This filing is a Form 4 statement detailing the adjustment in the executive's stock holdings.…more
$40.39+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.1After-hours26.10.02 05:32144Ownership
Septerna, Inc.
Insider Long Daniel D. of Septerna, Inc. has filed a Form 144 regarding the proposed sale of company securities. This filing serves as notification of the insider's plan to dispose of their holdings.…more
$40.39+0.00%vs prev closeView filingShare - 10.1After-hours26.10.02 05:24144Ownership
Septerna, Inc.
Insider Samira Shaikhly of Septerna, Inc. has filed a Form 144 regarding the proposed sale of company securities. This is a standard regulatory filing disclosing the insider's intent to sell shares.…more
$40.39+0.00%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.10After-hours26.09.11 05:00#●●●#●●●
Septerna Grants Stock Options to New Chief Medical Officer
Septerna has granted stock options for up to 275,000 shares to its newly appointed Chief Medical Officer, Dr. Rajiv Patni. This grant serves as a standard employment inducement and does not represent a material change in the company's financial fundamentals.…more
$40.39+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.1Pre-market26.09.01 21:00
●●●●●●●● ●●●●● ●●●●●●
Septerna announced its participation in the Wells Fargo and Cantor Fitzgerald healthcare investor conferences scheduled for September. This is a routine corporate communication regarding investor relations activities.…more
$40.39+0.00%vs prev close - 8.25Pre-market26.08.25 21:00
●●●●●●●● ●●●●● ●●●●●●
Clinical-stage biotech firm Septerna has appointed industry veteran Dr. Rajiv Patni as its new Chief Medical Officer. Dr. Patni will lead the company's clinical development programs for its GPCR-targeted oral medicines, leveraging his extensive experience in regulatory approvals.…more
$40.39+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report